Viking Therapeutics
Organization
Viking Therapeutics is a clinical-stage biotechnology company developing next-generation therapies for obesity and metabolic diseases. Its pipeline focuses on novel treatments intended to address significant unmet needs in metabolic health.
What experts have said about Viking Therapeutics
2 statements · 2 positive
Viking Therapeutics’ drug produced 22% weight loss over 33 weeks in a maintenance study.
“this drug led to a 22% weight loss over 33 weeks in what they call a maintenance study”
Open the episode · Alibaba and ON Rise; Viking Therapeutics SurgesListen at 3:17
Viking Therapeutics’ drug could compete with Eli Lilly and Novo Nordisk.
“it could be a contender to Eli Lilly and Novo Nordisk”
Open the episode · Alibaba and ON Rise; Viking Therapeutics SurgesListen at 3:24
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.
3 episodes featuring Viking Therapeutics
Stock Movers
AI demand lifts Everpure as markets punish weaker forecasts
The episode shows how investors are separating durable infrastructure demand from disappointing guidance and dilution risk during a market pullback.
Sep 24, 2026 · 6 min
Stock Movers
Obesity data lifts Viking as lab reimbursement cuts hit
The episode shows how clinical evidence, corporate strategy, and government payment policy can move very different stocks at once.
Sep 22, 2026 · 5 min
Stock Movers
Alibaba’s AI push meets rallies in apparel and biotech
The episode shows how technology investment, consumer-brand expansion, and drug-development data are moving distinct parts of the market.
Sep 22, 2026 · 6 min